butabarbital decreases results of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Coadministration of CYP3A4 inducers may perhaps lessen sufentanil concentrations and efficacy, probably precipitating withdrawal syndrome in sufferers who have created physical dependence to sufentanil. D